A, The Kv11.1 trafficking model consists of two-states (M: Membrane, S: Sub-membrane) with four rates (ψ: production rate, α: forward trafficking rate, β: internalisation rate, and δ: degradation rate). The temperature (θ), drugs (λ), and extracellular [K+] (κb and κd) parameters are used to scale the ψ, β, and δ rates. B, The Clancy and Rudy (2001)
IKr Markov model was used to create a temperature-sensitive model of IKr gating by shifting the voltage dependence of certain rates (see Table 2) and scaling each rate with their respective Q10 values (Clancy & Rudy, 2001). In particular, αn, βn, α2’, and μ rates were scaled with Q10Activation and Q10Deactivation, while αi and βi were scaled with Q10Inactivation and Q10Recovery, respectively. C, The trafficking, temperature, drug, and extracellular [K]+ components controlling IKr were embedded in the O’Hara-Rudy (ORd) human ventricular action potential model (O’Hara et al., 2011). Adapted from O’Hara et al. (2011) and the nucleus, endoplasmic reticulum (ER), and Golgi complex (GC) were created with BioRender.com.